Related Experiment Video
Updated: Mar 3, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells
1Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Abstract:
Bone morphogenetic protein (BMP) signaling exerts antitumor activities in glioblastoma; however, its precise mechanisms remain to be elucidated. Here, we demonstrated that the BMP type I receptor ALK-2 (encoded by the ACVR1 gene) has crucial roles in apoptosis induction of patient-derived glioma-initiating cells (GICs), TGS-01 and TGS-04. We also characterized a BMP target gene, Distal-less homeobox 2 (DLX2), and found that DLX2 promoted apoptosis and neural differentiation of GICs. The tumor-suppressive effects of ALK-2 and DLX2 were further confirmed in a mouse orthotopic transplantation model. Interestingly, valproic acid (VPA), an anti-epileptic compound, induced BMP2, BMP4, ACVR1 and DLX2 mRNA expression with a concomitant increase in phosphorylation of Smad1/5. Consistently, we showed that treatment with VPA induced apoptosis of GICs, whereas silencing of ALK-2 or DLX2 expression partially suppressed it. Our study thus reveals BMP-mediated inhibitory mechanisms for glioblastoma, which explains, at least in part, the therapeutic effects of VPA.
Insights
Bone morphogenetic protein (BMP) signaling inhibits glioblastoma by inducing apoptosis in glioma-initiating cells (GICs) via ALK-2 and DLX2. The anti-epileptic drug valproic acid (VPA) activates this pathway, offering therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Neuroscience
Background:
- Bone morphogenetic protein (BMP) signaling is implicated in glioblastoma (GBM) but its precise antitumor mechanisms require elucidation.
- Glioma-initiating cells (GICs) are key drivers of GBM, and understanding their regulation is critical for developing effective therapies.
Purpose of the Study:
- To investigate the role of BMP signaling, specifically the ALK-2 receptor and its target gene DLX2, in GIC apoptosis and neural differentiation.
- To explore the therapeutic potential of valproic acid (VPA) in modulating BMP signaling for glioblastoma treatment.
Main Methods:
- Utilized patient-derived GICs (TGS-01 and TGS-04) to study apoptosis and differentiation.
- Employed a mouse orthotopic transplantation model to validate tumor-suppressive effects in vivo.
- Analyzed gene expression (mRNA) and protein phosphorylation (Smad1/5) in response to VPA treatment.
- Investigated the effects of VPA on GICs, including ALK-2 and DLX2 silencing.
Main Results:
- BMP type I receptor ALK-2 (ACVR1) is crucial for inducing apoptosis in GICs.
- BMP target gene Distal-less homeobox 2 (DLX2) promotes GIC apoptosis and neural differentiation.
- Tumor-suppressive effects of ALK-2 and DLX2 were confirmed in vivo.
- Valproic acid (VPA) upregulates BMP2, BMP4, ACVR1, and DLX2, activating Smad1/5 phosphorylation and inducing GIC apoptosis.
- Silencing ALK-2 or DLX2 partially abrogated VPA-induced GIC apoptosis.
Conclusions:
- BMP signaling, mediated by ALK-2 and DLX2, exerts tumor-suppressive effects in glioblastoma by promoting GIC apoptosis and differentiation.
- Valproic acid (VPA) activates BMP signaling, explaining its therapeutic efficacy against glioblastoma.
- This study elucidates novel BMP-driven mechanisms against glioblastoma and highlights VPA as a potential therapeutic agent.
More Related Videos
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Regulation of Angiogenesis and Blood Supply